Airway epithelial NF-κB activation modulates asbestos-induced inflammation and mucin production in vivo

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1800-1808

  Haegens, Astrid ^a   Barrett, Trisha F ^a   Gell, Joanna ^a   Shukla, Arti ^a   MacPherson, Maximilian ^a   Vacek, Pamela ^b   Poynter, Matthew E ^b   Butnor, Kelly J ^a   Janssen Heininger, Yvonne M ^a   Steele, Chad ^c   Mossman, Brooke T ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CHEMOATTRACTANT; CHRYSOTILE; CLARA CELL PROTEIN; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASBESTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FIBROGENESIS; IN VIVO STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; TRANSGENIC MOUSE;

EID: 33846520676     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1800     Document Type: Article

References (37)

1. Mossman, B. T., and J. B. Gee. 1989. Asbestos-related diseases. N. Engl. J. Med. 320: 1721-1730.
2. Mossman, B. T., J. Bignon, M. Corn, A. Seaton, and J. B. Gee. 1990. Asbestos: scientific developments and implications for public policy. Science 247: 294-301.
3. Brody, A. R., and L. H. Overby. 1989. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos-exposed rats. Am. J. Pathol. 134; 133-140.
4. Robledo, R. F., S. A. Buder-Hoffmann, A. B. Cummins, E. S. Walsh, D. J. Taatjes, and B. T. Mossman. 2000. Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in mice. Am. J. Pathol. 156: 1307-1316.
5. Sabo-Attwood, T., M. Ramos-Nino, J. Bond, K. J. Butnor, N. Heintz, A. D. Gruber, C. Steele, D. J. Taatjes, P. Vacek, and B. T. Mossman. 2005. Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis. Am. J. Pathol 167: 1243-1256.
6. Christman, J. W., R. T. Sadikot, and T. S. Blackwell. 2000. The role of nuclear factor κB in pulmonary diseases. Chest 117: 1482-1487.
7. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and ReI proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
8. Janssen, Y. M., A. Barchowsky, M. Treadwell, K. E. Driscoll, and B. T. Mossman. 1995. Asbestos induces nuclear factor κB(NF-κB) DNA-binding activity and NF-κB-dependent gene expression in tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 92: 8458-8462.
9. Janssen, Y. M., K. E. Driscoll, B. Howard, T. R. Quinlan, M. Treadwell, A. Barchowsky, and B. T. Mossman. 1997. Asbestos causes translocation of p65 protein and increases NF-κB DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am. J. Pathol. 151: 389-401.
10. Janssen-Heininger, Y. M., M. E. Poynter, and P. A. Baeuerle. 2000. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic. Biol. Med. 28: 1317-1327.
11. Sanceau, J., T. Kaisho, T. Hirano, and J. Wietzerbin. 1995. Triggering of the human interleukin-6 gene by Interferon γ and tumor necrosis factor α in monocytic cells involves cooperation between Interferon regulatory factor-1, NF-κB, and Sp1 transcription factors. J. Biol. Chem. 270: 27920-27931.
12. Harant, H., R. de Martin, P. J. Andrew, E. Foglar, C. Dittrich, and I. J. Lindley. 1996. Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor α involves the transcription factor NF-κB. J. Biol. Chem. 271: 26954-26961.
13. Driscoll, K. E., D. G. Hassenbein, B. W. Howard, R. J. Isfort, D. Cody, M. H. Tindal, M. Suchanek, and J. M. Carter. 1995. Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J. Leukocyte Biol. 58: 359-364.
14. Poynter, M. E., R. Cloots, T. van Woerkom, K. J. Butnor, P. Vacek, D. J. Taatjes, C. G. Irvin, and Y. M. Janssen-Heininger. 2004. NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness. J. Immunol. 173: 7003-7009.
15. Goldberg, J. L., C. L. Zanella, Y. M. Janssen, C. R. Timblin, L. A. Jimenez, P. Vacek, D. J. Taatjes, and B. T. Mossman. 1997. Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos. Am. J. Respir. Cell Mol. Biol. 17: 265-271.
16. Poynter, M. E., C. G. Irvin, and Y. M. Janssen-Heininger. 2003. A prominent role for airway epithelial NF-κB activation in lipopolysaccharide-induced airway inflammation. J. Immunol. 170: 6257-6265.
17. Haegens, A., A. van der Vliet, K. J. Butnor, N. Heintz, D. Taatjes, D. Hemenway, P. Vacek, B. A. Freeman, S. L. Hazen, M. L. Brennan, and B. T. Mossman. 2005. Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res. 65: 9670-9677.
18. Campbell, W. C. H., and A. Wylie. 1980. U.S. Bureau of Mines Report of Investigations, No. 8452.
19. Hemenway, D. R., and S. M. MacAskill. 1982. Design, development and test results of a horizontal flow inhalation toxicology facility. Am. Ind. Hyg. Assoc. J. 43: 874-879.
20. Scholzen, T., and J. Gerdes. 2000. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182: 311-322.
21. Shukla, A., C. Timblin, K. BeruBe, T. Gordon, W. McKinney, K. Driscoll, P. Vacek, and B. T. Mossman. 2000. Inhaled particulate matter causes expression of nuclear factor (NF)-κB-related genes and oxidant-dependent NF-κB activation in vitro. Am. J. Respir. Cell Mol. Biol. 23: 182-187.
22. Polito, A. J., and D. Proud. 1998. Epithelia cells as regulators of airway inflammation. J. Allergy Clin. Immunol. 102: 714-718.
23. Buder-Hoffmann, S., C. Palmer, P. Vacek, D. Taatjes, and B. Mossman. 2001. Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 24: 405-413.
24. BeruBe, K. A., T. R. Quinlan, G. Moulton, D. Hemenway, P. O'Shaughnessy, P. Vacek, and B. T. Mossman. 1996. Comparative proliferative and histopathologic changes in rat lungs after inhalation of chrysotile or crocidolite asbestos. Toxicol. Appl. Pharmacol. 137: 67-74.
25. Manning, C. B., A. B. Cummins, M. W. Jung, I. Berlanger, C. R. Timblin, C. Palmer, D. J. Taatjes, D. Hemenway, P. Vacek, and B. T. Mossman. 2002. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression. Cancer Res. 62: 4169-4175.
26. Orlowski, R. Z., and A. S. Baldwin, Jr. 2002. NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8: 385-389.
27. Scapoli, L., M. E. Ramos-Nino, M. Martinelli, and B. T. Mossman. 2004. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23: 805-813.
28. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19: 5785-5799.
29. Portnoy, J., T. Pan, C. A. Dinarello, J. M. Shannon, J. Y. Westcott, L. Zhang, and R. J. Mason. 2006. Alveolar type II cells inhibit fibroblast proliferation: role of IL-1α. Am. J. Physiol. 290: L307-L316.
30. Selman, M., and A. Pardo. 2004. Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? Sarcoidosis Vasc. Diffuse Lung Dis. 21: 165-172.
31. Kibe, A., H. Inoue, S. Fukuyama, K. Machida, K. Matsumoto, H. Koto, T. Ikegami, H, Aizawa, and N. Hara. 2003. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am. J. Respir. Crit. Care Med. 167: 50-56.
32. Dabbagh, K., K. Takeyama, H. M. Lee, I. F. Ueki, J. A. Lausier, and J. A. Nadel. 1999. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 162: 6233-6237.
33. Takizawa, H., S. Abe, H. Okazaki, T. Kohyama, I, Sugawara, Y. Saito, T. Ohtoshi, S. Kawasaki, M. Desaki, K. Nakahara, et al. 2003. Diesel exhaust particles upregulate eotaxin gene expression in human bronchial epithelial cells via nuclear factor κB-dependent pathway. Am. J. Physiol. 284: L1055-L1062.
34. Mossman, B. T., and A. Churg. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157: 1666-1680,
35. Sadikot, R. T., W. Man, M. B. Everhart, O. Zoia, R. S. Peebles, E. D. Jansen, F. E. Yull, J. W. Christman, and T. S. Blackwell. 2003. Selective IκB kinase expression in airway epithelium generates neutrophilic lung inflammation. J. Immunol. 170: 1091-1098.
36. Sadikot, R. T., H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D. S. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell. 2006. Targeted immunomodulation of the NF-κB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J. Immunol. 176: 4923-4930.
37. Broide, D. H., T. Lawrence, T. Doherty, J. Y. Cho, M. Miller, K. McElwain, S. McElwain, and M. Karin. 2005. Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium. Proc. Natl. Acad. Sci. USA 102: 17723-17728.